汉森制药

- 002412

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2026  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
汉森制药(002412) 利润表
单位:万元
报表日期2026-06-302026-03-312025-12-312025-09-302025-06-30
一、营业总收入47,617.1926,322.84103,875.6774,079.3950,885.06
营业收入47,617.1926,322.84103,875.6774,079.3950,885.06
二、营业总成本37,566.8720,176.8680,262.6357,361.9037,299.49
营业成本10,298.925,449.2823,513.9917,007.9111,814.55
营业税金及附加942.13490.302,079.111,420.25930.29
销售费用20,714.7011,633.7943,029.2530,837.7719,020.02
管理费用3,927.501,703.917,664.225,323.243,641.94
财务费用8.883.3872.3248.7241.83
研发费用1,674.74896.203,903.742,724.011,850.87
资产减值损失----------
公允价值变动收益103.6560.92184.67139.4389.89
投资收益2,232.70-1,098.28634.82-5,563.48-3,949.76
其中:对联营企业和合营企业的投资收益1,916.86-1,206.09126.44-5,885.37-4,182.20
汇兑收益----------
三、营业利润12,227.594,831.4623,913.9211,354.399,735.27
加:营业外收入67.2111.1534.9718.7513.64
减:营业外支出14.582.5388.2461.6850.38
其中:非流动资产处置损失----------
四、利润总额12,280.234,840.0823,860.6511,311.469,698.52
减:所得税费用1,621.03999.434,048.603,058.932,844.68
五、净利润10,659.193,840.6419,812.048,252.526,853.84
归属于母公司所有者的净利润10,659.193,840.6419,812.048,252.526,853.84
少数股东损益----------
六、每股收益
基本每股收益(元/股)0.21180.07630.39370.16400.1362
稀释每股收益(元/股)0.21180.07630.39370.16400.1362
七、其他综合收益451.09359.79-2,057.89-2,508.21-1,620.54
八、综合收益总额11,110.284,200.4317,754.155,744.315,233.30
归属于母公司所有者的综合收益总额11,110.284,200.4317,754.155,744.315,233.30
归属于少数股东的综合收益总额----------
下载全部历史数据到excel中 返回页顶